TW201201857A - Agent suppressing decrease in preservative ability in amino-acid containing composition - Google Patents
Agent suppressing decrease in preservative ability in amino-acid containing composition Download PDFInfo
- Publication number
- TW201201857A TW201201857A TW100119456A TW100119456A TW201201857A TW 201201857 A TW201201857 A TW 201201857A TW 100119456 A TW100119456 A TW 100119456A TW 100119456 A TW100119456 A TW 100119456A TW 201201857 A TW201201857 A TW 201201857A
- Authority
- TW
- Taiwan
- Prior art keywords
- acid
- amino acid
- containing composition
- amino
- mass
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 37
- 239000003755 preservative agent Substances 0.000 title claims abstract description 20
- 230000002335 preservative effect Effects 0.000 title claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 title abstract description 8
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 claims abstract description 17
- 229930182847 D-glutamic acid Natural products 0.000 claims abstract description 15
- 150000008574 D-amino acids Chemical class 0.000 claims abstract description 11
- 239000002537 cosmetic Substances 0.000 claims abstract description 11
- BVHLGVCQOALMSV-NUBCRITNSA-N D-lysine hydrochloride Chemical compound Cl.NCCCC[C@@H](N)C(O)=O BVHLGVCQOALMSV-NUBCRITNSA-N 0.000 claims abstract description 6
- 238000005260 corrosion Methods 0.000 claims description 16
- 239000003112 inhibitor Substances 0.000 claims description 14
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims 2
- 239000000463 material Substances 0.000 abstract description 2
- 229940024606 amino acid Drugs 0.000 description 28
- 235000001014 amino acid Nutrition 0.000 description 25
- 238000009472 formulation Methods 0.000 description 19
- -1 p-hydroxybenzoic acid ester Chemical class 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000523 sample Substances 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 239000000443 aerosol Substances 0.000 description 8
- 229960005323 phenoxyethanol Drugs 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 239000013068 control sample Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229960005337 lysine hydrochloride Drugs 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- XKXHCNPAFAXVRZ-UHFFFAOYSA-N benzylazanium;chloride Chemical compound [Cl-].[NH3+]CC1=CC=CC=C1 XKXHCNPAFAXVRZ-UHFFFAOYSA-N 0.000 description 2
- 230000037319 collagen production Effects 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 108010028309 kalinin Proteins 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- HRYUPJAMBGBPIN-JEDNCBNOSA-N (2S)-2,6-diaminohexanoic acid guanidine Chemical compound NC(N)=N.NCCCC[C@H](N)C(O)=O HRYUPJAMBGBPIN-JEDNCBNOSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- WLRWTEIAYJHXDW-UHFFFAOYSA-N 2,2,3,3,4,4,4a,5,5,6-decamethyl-6H-cyclopenta[b]pyran Chemical compound CC1C=C2C(C(C(C(O2)(C)C)(C)C)(C)C)(C1(C)C)C WLRWTEIAYJHXDW-UHFFFAOYSA-N 0.000 description 1
- HYTMNLQEZZQQGN-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;2-ethylhexanoic acid Chemical compound OCC(CO)(CO)CO.CCCCC(CC)C(O)=O.CCCCC(CC)C(O)=O.CCCCC(CC)C(O)=O.CCCCC(CC)C(O)=O HYTMNLQEZZQQGN-UHFFFAOYSA-N 0.000 description 1
- SODXZRVMVYFUDO-UHFFFAOYSA-N 2-(2-hydroxypropoxy)propan-1-ol;propane-1,2,3-triol Chemical compound OCC(O)CO.CC(O)COC(C)CO SODXZRVMVYFUDO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- OUCGLXKNITVPJS-UHFFFAOYSA-N 2-ethylhexyl 3-phenylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=CC=C1 OUCGLXKNITVPJS-UHFFFAOYSA-N 0.000 description 1
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 1
- 239000004808 2-ethylhexylester Substances 0.000 description 1
- CRBJBYGJVIBWIY-UHFFFAOYSA-N 2-isopropylphenol Chemical compound CC(C)C1=CC=CC=C1O CRBJBYGJVIBWIY-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 244000089654 Betula populifolia Species 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- KIBSOJDHBVJPHE-UHFFFAOYSA-N C(CCCCCCCCCCCC)C(C(=O)O)(CCCCCCCC)OCCCCCCCCCC Chemical compound C(CCCCCCCCCCCC)C(C(=O)O)(CCCCCCCC)OCCCCCCCCCC KIBSOJDHBVJPHE-UHFFFAOYSA-N 0.000 description 1
- UGHZWUBHLABNDI-UHFFFAOYSA-N CC1C(C(OC=2C1C=CC2)(C)C)(C)C Chemical compound CC1C(C(OC=2C1C=CC2)(C)C)(C)C UGHZWUBHLABNDI-UHFFFAOYSA-N 0.000 description 1
- YOUGTRVLRLKAQI-UHFFFAOYSA-N CCCCCCCCCCC(C1=CC=C(C=C1)C(C)(C)C)C2=CC=C(C=C2)OCCCCCCCCCC Chemical compound CCCCCCCCCCC(C1=CC=C(C=C1)C(C)(C)C)C2=CC=C(C=C2)OCCCCCCCCCC YOUGTRVLRLKAQI-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 description 1
- 229930195715 D-glutamine Natural products 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- AALGOAOCFTUFLG-UHFFFAOYSA-N N,N-dioctadecylthiohydroxylamine Chemical compound C(CCCCCCCCCCCCCCCCC)N(S)CCCCCCCCCCCCCCCCCC AALGOAOCFTUFLG-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920000608 Polyaspartic Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000220151 Saxifragaceae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- ASWWWPTZUPOTHI-UHFFFAOYSA-N azanium cerium chloride Chemical compound [Ce].[Cl-].[NH4+] ASWWWPTZUPOTHI-UHFFFAOYSA-N 0.000 description 1
- UTMTYYKGLQURCK-UHFFFAOYSA-N butane-1,3-diol;propane-1,2,3-triol Chemical compound CC(O)CCO.OCC(O)CO UTMTYYKGLQURCK-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- WPJBQAROQHYNMO-UHFFFAOYSA-N echinoic acid Natural products CC(C)C1=CC=C(/C)CCC=C(CCC=C(/C)CC1)/C(=O)O WPJBQAROQHYNMO-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BDWFYHUDXIDTIU-UHFFFAOYSA-N ethanol;propane-1,2,3-triol Chemical compound CCO.OCC(O)CO BDWFYHUDXIDTIU-UHFFFAOYSA-N 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229960003707 glutamic acid hydrochloride Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 229960001269 glycine hydrochloride Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- ZRBSSYMJCKNFFZ-UHFFFAOYSA-N octadecylhydrazine Chemical compound CCCCCCCCCCCCCCCCCCNN ZRBSSYMJCKNFFZ-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- GJLNWLVPAHNBQN-UHFFFAOYSA-N phenyl 4-hydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OC1=CC=CC=C1 GJLNWLVPAHNBQN-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
201201857 六、發明說明: 【發明所屬之技術領域】 本發明係關於含D-胺基酸之含胺基酸組合物中之防腐力 降低抑制劑,具體言之,係關於含D_谷胺酸及/或d賴胺 酸鹽酸鹽之含胺基酸組合物中之防腐力降低抑制劑。 【先前技術】 化妝水、乳液、乳霜等化妝品通常將數十次之使用量填 充於1個容器内,使用時難以避免來自手指或空氣等之微 生物之混入。為防止化妝品因該微生物之變質,而於化妝 品中使用防腐劑。代表性化妝品用防腐劑包含異丙基甲基 苯酚、對羥基苯曱酸酯、2·苯氧乙醇、檜木醇等苯酚類、 苯甲酸及其鹽、水揚酸及其鹽、脫氫乙酸及其鹽、山梨酸 及其鹽等酸類、氯化苯烷銨、氯化芊銨、烷基三曱基氣化 銨等4級銨類、烷基胺基乙基甘胺酸鹽酸鹽、氯化硬脂醯 經基乙基甜菜驗鈉等兩性界面活性劑等。 但該等防腐劑有產生皮膚刺激者或如苯甲酸、水楊酸等 係會於低溫析出因此製劑之穩定性低者。再者,有如2_笨 氧乙醇般有揮發性因而揮發,於使用中化妝品之防腐力經 時降低者。 [利文獻1]本特開2006-249049號 【發明内容】 [明所欲解決之問題] 作為有保濕效果之化妝品成份或食品之營養成份’而調 配胺基酸或其鹽。但,先前調配之前述胺基酸(一般為^ I56307.doc 201201857 體)或其鹽變成微生物之營養源,有使調配物之防腐力下 降之問題。 因此’為了即使以儘可能低之濃度併用含胺基酸組合物 中調配之前述防腐劑仍具有充分防腐力,而需要開發出一 種含胺基酸組合物中之防腐力降低抑制劑。 [決問題之技術手段] 本發明提供一種含D-胺基酸之含胺基酸組合物中之防腐 力降低抑制劑。 本發明之含胺基酸組合物t之防腐力降低抑制劑中,前 述D-胺基酸有時為D-谷胺酸及/或D-賴胺酸鹽酸鹽。 本發明之含胺基酸組合物中之防腐力降低抑制劑之調配 量為0.000015質量0/〇至1〇質量% ’有時與〇 〇1質量%至1 〇質 量%之防腐劑併用。 本發明提供一種含有前述含胺基酸組合物中之防腐力降 低抑制劑之化妝品。 本說明書中,所謂含胺基酸組合物中之防腐力降低抑制 劑,意指單獨時雖無作為防腐劑之活性,但與其他防腐劑 併用時’可減低該防腐劑之調配量之組合物❶具體言之, 與先刖所調配之含胺基酸(L體)組合物相比,可提供—種 防腐劑量少即足夠之含胺基酸組合物。 本發明之含胺基酸組合物中之防腐力降低抑制劑不僅可 用於化妝品或皮膚外用劑,亦可使用於醫藥品、食品、飲 料以及有因微生物之混入而腐敗之虞之任一物品中之情 形0 156307.doc ⑧ 4· 201201857 本發明之含胺基酸組合物中之防腐力降低抑制劑所使用 之D-胺基酸包含由甘胺酸、丙胺酸、半胱胺酸、天冬胺 酸、谷胺酸、苯丙胺酸、組胺酸、異亮胺酸、賴胺酸、亮 胺酸、蛋胺酸、天門東素、脯胺酸、谷胺醯胺、精胺酸、 絲胺酸、棘胺酸、纈胺駿、色胺酸、酪胺酸所組成之2〇種 胺基酸中除甘胺酸外之19種胺基酸之立體異構物D_胺基 酸,與不限於該等之任一天然或非天然胺基酸。本發明之 申請人至今發現如曰本特願2009-2 11255(紫外線損害減輕 組合物)、日本特願2009-220983(紫外線損害減輕組合 物)、曰本特願2009-223327(紫外線損害減輕組合物)、曰 本特願2009-224742(抗氧化組合物)、日本特願2〇〇9_ 224743(促進膠原產生之組合物)、日本特願2〇〇9· 225870(促進膠原產生之組合物)、日本特願2〇〇9_ 225871(促進層粘連蛋白332產生之組合物)、日本特願 2009-225872(促進層粘連蛋白332產生之組合物)、日本特 願2009-226075(減輕皮膚粗糙之口服組合物)、日本特願 2009-226076(減輕皺紋形成之口服組合物)、日本特願 2009-228267(紫外線損害減輕之口服組合物)、 PCT/JP2〇10/53569(美白劑及美白皮膚之美容方法)、 PCT/JP2010/55841(紫外線損害減輕之口服組合物)、 PCT/JP2010/55842(抗氧化組合物)及 pcT/JP2010/55648(紫 外線損害減輕組合物)之各種申請說明書所說明,D_胺基 酸具有各種有用特性,基於該等發現而提供新穎之用途發 明。該等申請說明書之内容藉由引用其全體併入本說明書 156307.doc 201201857 中供參考。 有時與本發明之含胺基酸組合物中之防腐力降低抑制劑 併用之防腐劑,包含異丙基甲基苯酚、對羥基笨甲酸酯、 2-苯氧乙醇、檜木醇等㈣、苯甲酸及其鹽、水揚酸及其 鹽、脫氫乙酸及其鹽、山梨酸及其鹽等酸類、氯化苯炫 銨、氯化苄銨、烷基三甲基氣化銨等4級銨類、烷基胺基 乙基甘胺酸鹽酸鹽、氣化硬脂醯經基乙基甜菜驗鈉等兩性 界面活性劑等》但不限於該等。 【實施方式】 以下所說明之本發明之實施例僅以例示為目的,不限定 本發明之技術範圍。本發明之技術範圍僅由專利申請範圍 之記載所限定。 實施例1201201857 VI. Description of the Invention: [Technical Field] The present invention relates to a corrosion-inhibiting inhibitor in an amino acid-containing composition containing a D-amino acid, in particular, a D-glutamic acid-containing And/or an anti-corrosion reducing inhibitor in the amino acid-containing composition of d-lysamine hydrochloride. [Prior Art] Cosmetics such as lotions, lotions, and creams are usually filled in one container for dozens of times, and it is difficult to avoid the incorporation of microorganisms such as fingers or air during use. In order to prevent cosmetics from deteriorating due to the microorganism, preservatives are used in cosmetics. Representative cosmetic preservatives include isopropyl phenol, p-hydroxybenzoic acid ester, phenoxyethanol, phenolic acid such as benzyl alcohol, benzoic acid and its salts, salicylic acid and its salts, dehydroacetic acid and An acid such as a salt, a sorbic acid or a salt thereof, a quaternary ammonium chloride, an ammonium cerium chloride, an alkyl tridecyl ammonium halide, a 4- to ammonium, an alkylaminoethyl glycine hydrochloride, or a chlorine The stearyl hydrazine is subjected to an amphoteric surfactant such as sodium by a base beet test. However, such preservatives may cause skin irritation or such as benzoic acid, salicylic acid, etc., which may precipitate at a low temperature and thus have low stability of the preparation. Further, it is volatile as in the case of 2_oxyethanol, and volatilizes, and the antiseptic property of the cosmetic is lowered in use. [Problem 1] Unexamined Patent Publication No. 2006-249049 [Draft of the Invention] [A problem to be solved] An amino acid or a salt thereof is formulated as a cosmetic component having a moisturizing effect or a nutrient component of a food. However, the previously formulated amino acid (generally, I56307.doc 201201857) or a salt thereof becomes a nutrient source of microorganisms, and there is a problem that the antiseptic property of the formulation is lowered. Therefore, in order to have sufficient corrosion resistance even if the aforementioned preservative formulated in the amino acid-containing composition is used in the lowest possible concentration, it is required to develop an anti-corrosion reducing inhibitor in the amino acid-containing composition. [Technical means for solving the problem] The present invention provides a corrosion-inhibiting inhibitor in an amino acid-containing composition containing a D-amino acid. In the anti-corrosion reducing inhibitor of the amino acid-containing composition t of the present invention, the aforementioned D-amino acid is sometimes D-glutamic acid and/or D-lysine hydrochloride. The amount of the anti-corrosion reducing inhibitor in the amino acid-containing composition of the present invention is 0.000015 mass% / Torr to 1 〇 mass%, which is sometimes used in combination with 〇1% by mass to 1% by mass of the preservative. The present invention provides a cosmetic comprising the anti-corrosion reducing inhibitor in the aforementioned amino acid-containing composition. In the present specification, the anti-corrosion reducing inhibitor in the amino acid-containing composition means a composition which can reduce the amount of the preservative when used together with other preservatives, although it has no activity as a preservative alone. Specifically, an amino acid-containing composition having a small amount of preservative is provided as compared with the amino acid-containing (L body) composition formulated by the sputum. The antiseptic reducing agent in the amino acid-containing composition of the present invention can be used not only in cosmetics or skin external preparations, but also in medicines, foods, beverages, and any kind of articles which are spoiled by the incorporation of microorganisms. Case 0 156307.doc 8 4· 201201857 The D-amino acid used in the anti-corrosion reducing inhibitor of the amino acid-containing composition of the present invention comprises glycine, alanine, cysteine, aspartame Aminic acid, glutamic acid, phenylalanine, histidine, isoleucine, lysine, leucine, methionine, aspartame, valine, glutamine, arginine, silk a stereoisomer D-amino acid of 19 amino acids other than glycine in the amino acid consisting of acid, echinoic acid, guanamine, tryptophan and tyrosine, and It is not limited to any of these natural or non-natural amino acids. The applicant of the present invention has found, for example, that the Japanese Patent Application No. 2009-2 11255 (Ultraviolet Damage Reduction Composition), Japanese Patent Application No. 2009-220983 (Ultraviolet Damage Reduction Composition), and the Japanese Patent Application No. 2009-223327 (UV Damage Reduction Combination) ) 特 2009 2009-224742 (antioxidant composition), Japan's special offer 2〇〇9_ 224743 (composition for promoting collagen production), Japan's special offer 2〇〇9· 225870 (composition for promoting collagen production) ), Japanese special offer 2〇〇9_ 225871 (composition for promoting laminin 332), Japanese Patent No. 2009-225872 (combination for promoting laminin 332), Japanese Patent No. 2009-226075 (Reducing skin roughness) Oral composition), Japanese Patent Application No. 2009-226076 (oral composition for reducing wrinkle formation), Japanese Patent Application No. 2009-228267 (oral composition for reducing ultraviolet damage), PCT/JP2〇10/53569 (whitening agent and whitening) Various cosmetic application methods of PCT/JP2010/55841 (oral composition for reducing ultraviolet damage), PCT/JP2010/55842 (antioxidant composition), and pcT/JP2010/55648 (ultraviolet damage reduction composition) As indicated, D-amino acids have a variety of useful properties and provide novel uses based on such findings. The contents of these application notes are hereby incorporated by reference in its entirety by reference in its entirety by reference in its entirety in its entirety in its entirety in a preservative sometimes used in combination with a preservative lowering inhibitor in the amino acid-containing composition of the present invention, comprising isopropylmethylphenol, p-hydroxyformate, 2-phenoxyethanol, eucalypol, etc. (4), Benzoic acid and its salts, salicylic acid and its salts, dehydroacetic acid and its salts, acid such as sorbic acid and its salts, benzylammonium chloride, benzylammonium chloride, alkyltrimethylammonium vaporate, etc. Ammonium, alkylaminoethylglycine hydrochloride, vaporized stearin, amphoteric surfactant such as sodium formate test, etc., but not limited thereto. [Embodiment] The embodiments of the present invention described below are for illustrative purposes only and do not limit the technical scope of the present invention. The technical scope of the present invention is limited only by the description of the scope of the patent application. Example 1
防腐效果試驗係如下實施 或L_體0.5%(質量比, 。谷胺酸或賴胺酸鹽酸鹽之D· 以下相同)、5%之硝化甘油 (Dynamite glycerol)、〇.5%之2·苯氧乙醇溶解於剩餘之去 離子水中,調製樣本。未添加胺基酸之樣本作為對照使 用。對30 g樣本接種106 cfu/g之大腸桿菌或金黃葡萄球 菌,於25°C下保存。樣本調製時(0天)與保存第3、5、 1〇、14天,以無菌棉棒採取樣本之一部份,塗抹於瓊脂培 養基上,以30°C培養2天後,測量所形成之菌落數。菌落 數超過約100個之情形時,根據菌落數記錄為+++、及 +。菌落全然未形成時記錄為—。 防腐效果試驗之結果如以下表丨及表2所示。 156307.doc -6 · 201201857 [表1] 大腸桿菌 對照 谷β (0. Τ 5%) 賴胺酸鹽酸鹽 (0.5%) 第0天 +-H- ++Η- D +Ή-— L +-H- D HH- 弟3天 第5天 24 6 ··~~~-~~-— ++ 8 + 一 + 第7天 余10天 — 「1_2 — 66 〇7 — 窠14天 — — Z / 18 — [表2] 金黃葡萄 球菌 對照 谷月 (0. * 5%) 賴胺酸鹽酸鹽 (0.5%) 第0天 第3天 +++ -L +++ 一 — , L D +++ +++ +-H- 第5天 +++ 6 + 5 24 1 第7天 107 3 第10天 Γ 9 米1今穴 ------ 一 表1及表2分別係將利用接種有大腸桿菌及金黃葡萄球菌 之樣本之塗抹法之生菌數之測量結果彙總表。如表i所 示,接種有大腸桿菌之對照樣本十,確認樣本25t下保存 第3天及第5天檢測出生菌,但第7天後生菌全然未檢測 出。任一胺基酸之情形中,添加有^胺基酸之樣本中亦檢 測出比對照樣本多之生菌,但添加〇_胺基酸之樣本確認僅 檢測出比對照樣本少之生菌之傾向。如表2所示,接種有 金黃葡萄⑨®之樣本在添加L_胺基酸之樣纟中亦檢測出比 對照樣本多之生菌,但添加有D_胺基酸之樣本中僅檢測出 比L-胺基酸少之菌數。另,該等樣本調製時之均在 至6.1之範圍内,可知不會對大腸桿菌及金黃葡萄球菌之 增殖帶來太大影響。又,相同胺基酸之1_體與D_體中口^相 同。因此,認為所添加之胺基酸之光學異性之差異係對生 156307.doc 201201857 菌數帶來較大差異之原因。即,L_胺基酸使2_苯氧乙醇之 防腐力降低,但D-胺基酸抑制2_笨氧乙醇之防腐力降低。 D-谷胺酸及D-賴胺酸鹽酸鹽抑制2_苯氧乙醇之防腐力降低 之效果顯著。 實施例2 以下係基於本發明,顯示含D_谷胺酸及/或〇_賴胺酸鹽 酸顏之飲料、乳霜、身體用乳霜、凝膠劑、剝離式面膜、 浸透式面膜、乳液、化妝水及氣溶膠劑之調配例。該等調 配例係以例示為目的而列舉者,不意圖限定本發明之技術 範圍。 調配例1(飲料) 調配量(g/60 mL中) 1.6 1.6 (組合物) 金銀花提取物 人參提取物 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 1>6 還原麥芽糖糖漿 28 赤蘚糖醇 8 檸檬酸 2 香料 1.3 N-乙醯葡萄糖胺 1 透明質酸鈉 0.5 維他命E 0.3 維他命B6 〇.2 156307.doc 201201857 維他命B 2 0.1 α-硫辛酸 0.2 輔酶Q10 1.2 神經醯胺(魔芋提取物) 0.4 L-脯胺酸 2 純水 剩餘 60 調配量(質量%) 3 1The antiseptic effect test was carried out as follows: L_body 0.5% (mass ratio, glutamic acid or lysine hydrochloride D· the same below), 5% nitroglycerin (Dynamite glycerol), 〇.5% of 2 • Phenoxyethanol is dissolved in the remaining deionized water to prepare a sample. A sample without added amino acid was used as a control. A 30 g sample was inoculated with 106 cfu/g of Escherichia coli or Staphylococcus aureus and stored at 25 °C. When the sample was prepared (0 days) and stored for 3, 5, 1 and 14 days, a part of the sample was taken with a sterile cotton swab, spread on an agar medium, and cultured at 30 ° C for 2 days, and the measurement was formed. The number of colonies. When the number of colonies exceeds about 100, the number of colonies is recorded as +++, and +. Recorded as - when the colony was not formed at all. The results of the antiseptic effect test are shown in Tables 2 and 2 below. 156307.doc -6 · 201201857 [Table 1] Escherichia coli control trough β (0. Τ 5%) lysine hydrochloride (0.5%) Day 0 +-H- ++Η- D +Ή-- L +-H- D HH- Brother 3 days 5th day 24 6 ··~~~-~~-- ++ 8 + one + 10 days in the 7th day - "1_2 — 66 〇 7 — 窠 14 days — Z / 18 — [Table 2] Staphylococcus aureus control Gu Yue (0. * 5%) lysine hydrochloride (0.5%) Day 0 Day 3 +++ -L +++ I -- , LD + ++ +++ +-H- Day 5 +++ 6 + 5 24 1 Day 7 107 3 Day 10 Γ 9 m 1 Today ------ One Table 1 and Table 2 will be utilized separately A summary of the results of the measurement of the number of bacteria inoculated with a sample of Escherichia coli and Staphylococcus aureus. As shown in Table i, a control sample of Escherichia coli was inoculated, and the sample was confirmed to be stored on the 3rd and 5th day at 25t. The bacteria were detected, but the bacteria were not detected at the 7th day. In the case of any amino acid, more bacteria than the control sample were detected in the sample with the amino acid added, but the 〇-amino group was added. The acid sample confirmed that only the tendency of the bacteria to be less than the control sample was detected. As shown in Table 2, inoculation The sample of Golden Grape 9® also detected more bacteria than the control sample in the sample containing L_amino acid, but only the sample added with D_amino acid detected less than L-amino acid. The number of bacteria is also in the range of 6.1, which does not affect the proliferation of Escherichia coli and Staphylococcus aureus. Also, the 1_body and D_ of the same amino acid The difference in optical heterogeneity of the added amino acid is considered to be the reason for the large difference in the number of bacteria of 156307.doc 201201857. That is, L_amino acid makes 2-phenoxyethanol The anti-corrosion power is lowered, but the D-amino acid inhibits the reduction of the anti-corrosion power of the 2-phenyl alcohol. D-glutamic acid and D-lysine hydrochloride have a remarkable effect of inhibiting the reduction of the anti-corrosion of 2-phenoxyethanol. Example 2 The following is based on the present invention and shows a beverage containing D_glutamic acid and/or guanidine-lysine acid, a cream, a body cream, a gel, a peeling mask, a soaking mask, Examples of the preparation of emulsions, lotions, and aerosols. These formulations are listed for the purpose of illustration and are not intended to limit the present invention. Technical range. Formulation Example 1 (beverage) Formulation amount (g/60 mL) 1.6 1.6 (Composition) Honeysuckle extract Ginseng extract D-glutamic acid and/or D-lysine hydrochloride 1> 6 Reducing Maltose Syrup 28 Erythritol 8 Citric Acid 2 Perfume 1.3 N-Acetyl Glucosamine 1 Sodium Hyaluronate 0.5 Vitamin E 0.3 Vitamin B6 〇.2 156307.doc 201201857 Vitamin B 2 0.1 α-Lipoic Acid 0.2 Coenzyme Q10 1.2 Neural guanamine (konjac extract) 0.4 L-proline 2 pure water remaining 60 ration (% by mass) 3 1
8 5 2 3 6 2 0.5 4 0.5 m 3 調配例2(乳霜) 液體石蠟 凡士林 二曱基聚矽氧烷 硬脂醇 山窬醇 甘油 二丙二醇 澳洲堅果油 硬化油 角鯊烷 硬脂酸 羥基硬脂酸膽固醇酯 2 -乙基己酸十六烧酉旨 聚氧乙烯硬化蓖麻油 自乳化型單硬脂酸甘油 156307.doc 201201857 氫氧化鉀 0.15 六偏磷酸鈉 0.05 三甲基甘胺酸 2 α-生育酚2-L-抗壞血酸 磷酸二酯鉀 1 醋酸生育酚 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.5 對羥基苯甲酸酯 適量 乙二胺四乙酸三鈉 0.05 4-t-丁基-4’-曱氧基二苯甲醯曱烷 0.05 二對曱氧基肉桂酸單-2- 乙基己酸甘油酯 0.05 著色劑 適量 叛乙稀聚合物 0.05 純水 剩餘 100.00 調配例3(身體用乳液) 調配量(質量%) 3 13 12 (組合物) 二甲基聚矽氧烷 十甲基環五矽氧烷 十二曱基環六矽氧烷 聚氧乙烯·甲基聚矽氧烷共聚物 156307.doc -10· 201201857 乙醇 2 異丙醇 1 甘油 3 二丙二醇 5 聚乙二醇6000 5 六偏磷酸鈉 0.05 醋酸生育酚 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.1 茴香提取物 0.1 金縷梅提取物 0.1 人參提取物 0.1 L-薄荷醇 適量 對羥基苯甲酸酯 適量 乙二胺四乙酸三鈉 0.05 二嗎淋基璉°秦酮 0.01 三甲氧基肉桂酸甲基雙(三曱基矽氧基) 矽烷基異戊酯 0.1 黃色氧化鐵 ‘適量 鈦酸錄 適量 二曱基二硬脂基銨水輝石 1.5 聚乙烯醇 0.1 羥乙基纖維素 0.1 三曱基矽烷氧基矽酸 2 156307.doc -π - 201201857 香料 純水 適量 剩餘 100.00 調配例4(凝膠劑) (組合物) 二甲基聚矽氧烷 甘油 1,3-丁二醇 聚乙二醇1500 聚乙二醇20000 辛酸十六烷酯 檸檬酸 檸檬酸鈉 六偏磷酸鈉 甘草酸二钟 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 醋酸生育酚 黃芩提取物 虎耳草提取物 乙二胺四乙酸三鈉 黃原膠 丙烯酸·甲基丙烯酸 調配量(質量°/〇) 5 2 5 3 3 3 0.01 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 156307.doc -12- 201201857 烧醋共聚物(Pemulen TR-2) 0.05 瓊脂粉 1.5 2-苯氧乙醇 適量 二丁基羥基曱苯 適量 純水 剩餘 100.00 調配例5(剝離式面膜) (組合物) 調配量(質量%) 乙醇 10 1,3-丁二醇 聚乙二醇 橄欖油 澳洲堅果油 羥基硬脂酸植物甾醇 乳酸 乳酸納 L-抗壞血酸硫酸酯2鈉 α-生育酚2-L-抗壞血 酸麟酸二S旨奸 6 2 0.05 0.058 5 2 3 6 2 0.5 4 0.5 m 3 Formulation Example 2 (cream) Liquid paraffin Vaseline dimercapto polyoxyalkylene stearyl behenyl glycerol dipropylene glycol macadamia nut oil hardening oil squalane stearic acid hydroxy hard Cholesteric acid cholesterol ester 2-ethylhexanoic acid hexahydrate 酉 聚 polyoxyethylene hardened castor oil self-emulsifying monostearic acid glycerol 156307.doc 201201857 potassium hydroxide 0.15 sodium hexametaphosphate 0.05 trimethylglycine 2 α - Tocopherol 2-L-ascorbyl phosphate diester potassium 1 Tocopherol acetate 0.1 D-glutamic acid and / or D-lysamine hydrochloride 0.5 Parabens amount Ethylenediaminetetraacetic acid trisodium 0.05 4 -t-butyl-4'-decyloxybenzophenone 0.05 di-p-oxy cinnamic acid mono-2-ethylhexanoic acid glyceride 0.05 coloring agent appropriate amount of tethered polymer 0.05 pure water remaining 100.00 Formulation Example 3 (Body Emulsion) Formulation amount (% by mass) 3 13 12 (Composition) Dimethyl polyoxane decamethylcyclopentaoxane, 12-fluorenylcyclohexaoxane, polyoxyethylene, A Polyoxyalkylene copolymer 156307.doc -10· 201201857 Ethanol 2 Isopropanol 1 Glycerin 3 Dipropylene glycol 5 Polyethylene glycol 6000 5 Sodium metaphosphate 0.05 Tocopherol acetate 0.1 D-glutamic acid and/or D-lysine hydrochloride 0.1 Fennel extract 0.1 Witch hazel extract 0.1 Ginseng extract 0.1 L-menthol Phenyl paraben Appropriate amount of trisodium edetate 0.05 吗 淋 琏 琏 秦 酮 0.01 0.01 0.01 0.01 Trimethoxy cinnamic acid methyl bis (tridecyl decyloxy) decyl isoamyl ester 0.1 yellow iron oxide 'the right amount of titan acid recorded two Mercapto distearyl ammonium hectorite 1.5 polyvinyl alcohol 0.1 hydroxyethyl cellulose 0.1 tridecyl decyloxy decanoic acid 2 156307.doc -π - 201201857 Perfume pure water amount remaining 100.00 Preparation example 4 (gelling agent) (composition) dimethyl polyoxyalkylene glycerol 1,3-butanediol polyethylene glycol 1500 polyethylene glycol 20000 cetyl octyl citrate citrate sodium hexametaphosphate glycyrrhizic acid two D-valley Amino acid and / or D-lysamine hydrochloride tocopherol extract Astragalus extract Saxifrag extract Ethylenediaminetetraacetic acid trisodium xanthan gum Acrylic acid / Methacrylic acid blending amount (mass ° / 〇) 5 2 5 3 3 3 0.01 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 156307.doc -12- 201201857 Polymer (Pemulen TR-2) 0.05 Agar powder 1.5 2-Phenoxyethanol Appropriate amount of dibutylhydroxyindole Benzene Appropriate amount of pure water remaining 100.00 Formulation Example 5 (peeling mask) (composition) Formulation amount (% by mass) Ethanol 10 1 ,3-butanediol polyethylene glycol olive oil macadamia nut oil hydroxystearic acid plant sterol lactate lactate L-ascorbyl sulfate 2 sodium alpha-tocopherol 2-L-ascorbate two S-sex 6 6 0.05
D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.1 魚膠原 0.1 硫酸軟骨素鈉 0.1 156307.doc -13- 201201857 羥甲纖維素鈉 0.2 聚乙烯醇 12 對羥基苯甲酸酯 適量 香料 適量 純水 剩餘 100.00 調配例6(浸透式面膜) (組合物) 調配量(質量%) 甘油 1 1,3-丁二醇 8 木糖醇 2 聚乙二醇1500 2 迷迭香油 0.01 鼠尾草油 0.1 檸檬酸 0.02 檸檬酸鈉 0.08 六偏磷酸鈉 0.01 羥丙基-β-環糊精 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.5 白樺提取物 0.1 薰衣草油 0.01 黃原膠 0.05 156307.doc -14· 201201857 羧基乙烯聚合物 對羥基苯甲酸酯 純水 調配例7(乳液) (組合物) 液體石蠟 凡士林 十五甲基環五矽氧烷 山茶醇 甘油 二丙二醇 聚乙二醇1500 荷荷巴油 異硬脂酸 硬脂酸 山蓊酸 四(2-乙基己酸)季戊四醇酯 2 -乙基己酸十六烧酉旨 單硬脂酸甘油酯 單硬脂酸聚氧乙烯甘油酯 氫氧化鉀 六偏填酸納 0.15 適量 剩餘 100.00 調配量(質量%) 7 3 2 1.5 5 7 2 1 0.5 0.5 0.5 3 3 0.05 156307.doc 15 201201857 甘草次酸硬脂酯 0.05 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 1 蜂王漿提取物 0.1 酵母提取物 0.1 醋酸生育酚 0.1 乙醯化透明質酸鈉 0.1 乙二胺四乙酸三鈉 0.05 4-t-丁基-4'-曱氧基二苯甲醯基曱烷0.1 對甲氧基桂皮酸2-乙基己酯 0.1 羧基乙烯聚合物 0.15 對羥苯甲酸酯 適量 香料 適量 純水 剩餘 100.00 調配例8(乳液) (組合物) 調配量(質量%) 二甲基聚矽氧烷 2 山蓊醇 1 鯊肝醇 0.5 甘油 5 1,3-丁二醇 7 赤蘚糖醇 2 156307.doc -16- 201201857 硬化油 3 角鯊烯 6 四(2-乙基己酸)季戊四醇酯 2 異硬脂酸聚氧乙烯甘油 1 單硬脂酸聚氧乙烯甘油 1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.3 氫氧化鉀 適量 六偏磷酸鈉 0.05 2-苯氧乙醇 適量 羧基乙烯聚合物 0.1 純水 剩餘 調配例9(化妝水) (組合物) 乙醇 甘油 100.00 調配量(質量%) 5 1,3-丁二醇 5 聚環氧乙烷聚環氧丙烷 癸基十四烷基醚 0.2 六偏磷酸鈉 0.03 三甲基甘胺酸 1 聚天冬醯胺酸鈉 0.1 156307.doc •17- 201201857 α-生育酚2-抗壞血酸 磷酸二酯鉀 0.1 硫代牛磺酸 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.01 EDTA3鈉 0.1 羧基乙烯基聚合物 0.05 氫氧化鉀 0.02 2-苯氧乙醇 適量 香料 適量 純水 剩餘 anoea·——a—ani, a ιι 丨_ ga—aesanaiaca—casaaagaca—aegxaasaMnae—iea!ani,.mn_i8»acceaiEsa 100.00 調配例10(化妝水) (組合物) 調配(I 乙醇 10 二丙二醇 1 聚乙二醇1000 1 聚氧乙烯甲基葡糖苷 1 荷荷巴油 0.01 三2-乙基己酸甘油酯 0.1 聚氧乙烯硬化蓖麻油 0.2 二異硬脂酸聚甘油酯 0.15 N-硬脂醯基-L-谷胺酸鈉 0.1 •18- 156307.doc 201201857 檸檬酸 0.05 擰檬酸鈉 0.2 氫氧化鉀 0.4 甘草酸二鉀 0.1 精胺酸鹽酸鹽 0.1 L-抗壞血酸2-葡糖苷 2 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.5 乙二胺四乙酸三鈉 0.05 對曱氧基桂皮酸2-乙基己酯 0.01 二丁基羥基曱苯 適量 對羥基苯曱酸酯 適量 海洋深層水 3 香料 適量 純水 剩餘 100.00 調配例11(氣溶膠尿素外用劑原液) (組合物) 調配量 乙醇 15.0 聚氧乙烯硬化蓖麻油50 1.5 二苯海拉明 1.0 辛可卡因(dibucaine) 2.0 醋酸生育酚 0.5 -19- 156307.doc 201201857 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.1 異硬脂酸 0.1 1,3-丁二醇 3.0 聚乙二醇4〇〇 3.0 樟腦 0.05 尿素 20.0 純水 剩餘 100.00 調配例12(氣溶膠尿素喷射劑) (組合物) 調配量(質量〇/〇) 氣溶膠展素外用劑原液 65.0 35.0 二甲醚 100.00 調配例12(氣溶膠尿素喷射劑)之填充方法 將氣溶膠尿料用劑原液及2甲趟填充於内©經鐵氟隆 (註冊商標)塗佈處理之耐壓氣溶膠鋁罐内,調製氣溶膠 劑。 156307.docD-glutamic acid and/or D-lysamine hydrochloride 0.1 Fish collagen 0.1 Chondroitin sulfate 0.1 156307.doc -13- 201201857 Sodium hydroxymethylcellulose 0.2 Polyvinyl alcohol 12 Parabens Appropriate amount of pure water remaining 100.00 Formulation Example 6 (Immersion Mask) (Composition) Formulation amount (% by mass) Glycerin 1 1,3-butanediol 8 Xylitol 2 Polyethylene glycol 1500 2 Rosemary oil 0.01 Sage Oil 0.1 Citric acid 0.02 Sodium citrate 0.08 Sodium hexametaphosphate 0.01 Hydroxypropyl-β-cyclodextrin 0.1 D-glutamic acid and / or D-lysamine hydrochloride 0.5 White birch extract 0.1 Lavender oil 0.01 Huangyuan Gum 0.05 156307.doc -14· 201201857 Carboxyvinyl polymer p-hydroxybenzoate pure water formulation Example 7 (emulsion) (composition) Liquid paraffin Vaseline pentamethylcyclopentaoxane Camelliere glycerol dipropylene glycol polyethylene Glycol 1500 jojoba oil isostearic acid stearic acid behenic acid tetrakis(2-ethylhexanoic acid) pentaerythritol ester 2-ethylhexanoic acid hexahydrate glycerol monostearate monostearate Oxyethylene glyceride potassium hydroxide hexaploxate 0.15 appropriate amount of remaining 100.00 Mass%) 7 3 2 1.5 5 7 2 1 0.5 0.5 0.5 3 3 0.05 156307.doc 15 201201857 Glycyrrhetinic acid stearyl ester 0.05 D-glutamic acid and / or D-lysamine hydrochloride 1 Royal jelly extract 0.1 Yeast Extract 0.1 Tocopherol Acetate 0.1 Acetate Sodium Hyaluronate 0.1 Ethylenediaminetetraacetic Acid Trisodium 0.05 4-t-Butyl-4'-decyloxybenzhydryldecane 0.1 P-Methoxy Cinnamon Acid 2-ethylhexyl ester 0.1 Carboxyvinyl polymer 0.15 Parabens Appropriate amount of spices Right amount of pure water remaining 100.00 Formulation Example 8 (emulsion) (composition) Formulation amount (% by mass) Dimethylpolysiloxane 2 Kaempferol 1 Shark liver alcohol 0.5 Glycerol 5 1,3-butanediol 7 Erythritol 2 156307.doc -16- 201201857 Hardened oil 3 Squalene 6 Tetrakis(2-ethylhexanoate) pentaerythritol 2 Stearic acid polyoxyethylene glycerol 1 monostearate polyoxyethylene glycerol 1 D-glutamic acid and / or D-lysamine hydrochloride 0.3 potassium hydroxide amount of sodium hexametaphosphate 0.05 2-phenoxyethanol appropriate amount of carboxyl Ethylene polymer 0.1 pure water remaining formulation example 9 (makeup) (composition) ethanol glycerin 100.00 dosage (% by mass) 5 1,3-butanediol 5 polyethylene oxide polypropylene oxide decyltetradecyl ether 0.2 sodium hexametaphosphate 0.03 trimethylglycine 1 polyaspartic sodium citrate 0.1 156307.doc • 17- 201201857 α-Tocopherol 2-Ascorbyl Phosphate Diester Potassium 0.1 Thio Taurine 0.1 D-Glutamic Acid and/or D-Lysamine Hydrochloride 0.01 EDTA3 Sodium 0.1 Carboxyvinyl Polymer 0.05 Potassium Hydroxide 0.02 2-phenoxyethanol, the right amount of spices, the amount of pure water remaining anoea·——a—ani, a ιι 丨_ ga—aesanaiaca—casaaagaca—aegxaasaMnae—iea!ani,.mn_i8»acceaiEsa 100.00 Formulation Example 10 (lotion) (Combination Formulation (I ethanol 10 dipropylene glycol 1 polyethylene glycol 1000 1 polyoxyethylene methyl glucoside 1 jojoba oil 0.01 triethyl 2-ethylhexanoate 0.1 polyoxyethylene hardened castor oil 0.2 diisostearyl Acid polyglyceride 0.15 N-stearyl sulfhydryl-L-glutamate 0.1 • 18- 156307.doc 201201857 Citric acid 0.05 sodium citrate 0.2 potassium hydroxide 0.4 dipotassium glycyrrhizinate 0.1 arginine hydrochloride 0.1 L-ascorbic acid 2-glucoside 2 D-glutamic acid and / or D-lysamine hydrochloride 0.5 Ethylenediaminetetraacetic acid trisodium 0.05 p-Oxyl cinnamic acid 2-ethylhexyl ester 0.01 Dibutyl hydroxy fluorene benzophenone p-hydroxyphenyl phthalate Appropriate amount of marine deep water 3 Perfume amount of pure water remaining 100.00 Preparation example 11 ( Aerosol urea external preparation) (composition) Formulation ethanol 15.0 Polyoxyethylene hardened castor oil 50 1.5 Diphenhydramine 1.0 dicocaine 2.0 Tocopherol acetate 0.5 -19- 156307.doc 201201857 D-glutamine Acid and / or D-lysamine hydrochloride 0.1 isostearic acid 0.1 1,3-butanediol 3.0 polyethylene glycol 4 〇〇 3.0 camphor 0.05 urea 20.0 pure water remaining 100.00 Preparation example 12 (aerosol urea injection Agent) (composition) Formulation amount (mass 〇 / 〇) Aerosol exhibitant external preparation stock solution 65.0 35.0 Dimethyl ether 100.00 Preparation method 12 (aerosol urea spray agent) filling method Aerosol urine material preparation liquid and 2 The formazan is filled in a pressure-resistant aerosol aluminum can coated with Teflon (registered trademark) to prepare an aerosol. 156307.doc
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010132388A JP2011256137A (en) | 2010-06-09 | 2010-06-09 | Agent suppressing decrease in preservative ability in amino acid-containing composition |
| PCT/JP2011/060904 WO2011155280A1 (en) | 2010-06-09 | 2011-05-12 | Agent suppressing decrease in preservative ability in amino-acid containing composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201201857A true TW201201857A (en) | 2012-01-16 |
Family
ID=45097892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW100119456A TW201201857A (en) | 2010-06-09 | 2011-06-02 | Agent suppressing decrease in preservative ability in amino-acid containing composition |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2011256137A (en) |
| TW (1) | TW201201857A (en) |
| WO (1) | WO2011155280A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3047495A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Topical skin lightening additive and composition with amino acids and nicotinamide compounds |
| US11337908B2 (en) | 2016-12-21 | 2022-05-24 | Conopco, Inc. | Personal care compositions with cystine |
| WO2018114745A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions comprising poorly soluble compounds |
| US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
| EP3822288A1 (en) * | 2019-11-18 | 2021-05-19 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Antibodies targeting, and other modulators of, the cd276 antigen, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57158724A (en) * | 1981-03-26 | 1982-09-30 | Shiseido Co Ltd | Antimicrobial composition |
| JPH05229924A (en) * | 1992-02-25 | 1993-09-07 | Nippon Zetotsuku Kk | Composition for oral cavity |
| JP2521632B2 (en) * | 1993-04-19 | 1996-08-07 | 花王株式会社 | Hair deformer composition |
| AU4068400A (en) * | 1999-05-06 | 2000-11-21 | Biospherics Incorporated | Method for preventing or minimizing biodegradation of a substance |
-
2010
- 2010-06-09 JP JP2010132388A patent/JP2011256137A/en not_active Withdrawn
-
2011
- 2011-05-12 WO PCT/JP2011/060904 patent/WO2011155280A1/en not_active Ceased
- 2011-06-02 TW TW100119456A patent/TW201201857A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011256137A (en) | 2011-12-22 |
| WO2011155280A1 (en) | 2011-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6653342B2 (en) | Topical oil compositions for the treatment of fungal infections | |
| EP2405885B1 (en) | Thickening additive compositions for sunscreen formulations | |
| JP5637987B2 (en) | Preservative composition | |
| CN1242701A (en) | Compositions contg. antifungal and cationic agent | |
| JP5507146B2 (en) | Water-in-oil emulsified paste pharmaceutical preparation for lips | |
| SA109300373B1 (en) | Compositions for Lightening Skin Color | |
| TW201201857A (en) | Agent suppressing decrease in preservative ability in amino-acid containing composition | |
| JP5302239B2 (en) | Antiseptic disinfectant and human body composition | |
| JP2018127445A (en) | Composition for external use | |
| JP5550863B2 (en) | Cosmetics | |
| CZ295985B6 (en) | Body and hair cleansing composition containing fungicidal agent and phospholipid as well as process for preparing such composition | |
| JP2019210250A (en) | Preservative composition containing isopentyldiol | |
| JP2007169192A (en) | Hair cosmetics | |
| JP6971518B2 (en) | Antibacterial composition containing thymol, terpineol, and cationic phospholipids | |
| KR20160044071A (en) | Preservative composition containing methyl 3-acetyl-4-hydroxybenzoate as an active ingredient | |
| JP5013753B2 (en) | Antiseptic disinfectant composition | |
| KR101585795B1 (en) | Preservative composition containing diethylene glycol monobenzyl ether as an active ingredient | |
| JP5264829B2 (en) | Antiseptic disinfectant and cosmetic composition | |
| JP2018052887A (en) | Aqueous preparation | |
| JP6900121B2 (en) | Antiperspirant composition and antiperspirant | |
| JP2018052886A (en) | Aqueous formulation | |
| JP2009167139A (en) | External use composition | |
| JP4294640B2 (en) | Antiseptic disinfectant, cosmetics or pharmaceuticals containing the antiseptic disinfectant, and antiseptic disinfection method | |
| CN109939090A (en) | novel use | |
| TW201345558A (en) | External preparation for skin |